Despite treatment with intravenous immunoglobulin, the patient still passed away

Despite treatment with intravenous immunoglobulin, the patient still passed away. meant that she was no longer able to perform activities of daily living. She experienced a medical history of main squamous cell carcinoma of the tongue that experienced recurred postresection, a postirradiation gingival sarcoma and a mandibular spindle cell PF-04979064 (sarcomatoid) squamous cell carcinoma. There was no history of alcohol misuse or a significant family history. On exam, she was alert and orientated having a sinus tachycardia of 120 bpm and oxygen saturations of 82% on space air flow. Her conjunctivae were pale. Respiratory, abdominal and cardiovascular examinations were unremarkable. Neurological exam revealed a weakness of all limbs, related to Medical Study Council grade 4/5 in all ranges of movement. No fasciculations were mentioned. Cerebellar and cranial nerve indicators were absent. Light touch sensation was absent to the knees bilaterally with pain sensation absent to the level of mid-tibia bilaterally. These signs were symmetrical. There was decreased light touch and pain sensation of both hands. There were absent deep tendon reflexes in the legs and both plantars were downgoing. Reflexes in the arms were brisk. In the following fortnight, her neurological symptoms worsened with ascending paraesthesia to the waist and decreasing power in the lower limbs. The areflexia progressed to involve all reflexes in the upper limbs where there was also progressive sensory loss to the elbows, but with retained power. The working diagnosis was Guillain-Barr syndrome (GBS) secondary to a para-neoplastic process. Cdc14B1 The patient was too unwell to travel to the neurological unit for nerve conduction studies. Serial vital capacity measurements were undertaken twice daily and reduced over time. == Investigations == The patient had a normocytic anaemia (9.7 g/dl), thrombocytosis (753109/l) and a neutrophilia (neutrophil count of 11.1109/l). Renal, hepatic and thyroid functions were normal. In addition laboratory assessments including antinuclear antibody, serology PF-04979064 forCampylobacter jejuni,HIV, cytomegalovirus and Borrelia and urinalysis (including 5-hydroxyindoleacetic-acid and catecholamines) proved negative. Cerebrospinal fluid (CSF) analysis 5 days postadmission showed no significant cellularity, normal plasma:CSF glucose ratio, no organisms on Gram staining, but PF-04979064 a raised protein of 506.7 mg/l. Owing to the lack of a clear focus of pathology, a whole body positron emission tomography scan was performed that showed multifocal intense flurorodeoxyglucose uptake within numerous bones (physique 1) and the right lobe of the thyroid. Ultrasound scan of the thyroid showed a heterogeneous appearance with no suitable nodules for fine needle aspiration. A left sacral alar biopsy (physique 2) was obtained under CT guidance. This showed metastatic poorly differentiated squamous cell carcinoma with some spindle/sarcomatous differentiation and areas of signet-ring-like morphology (physique 3). This was judged likely to be a metastatic recurrence of the previous neoplastic lesion in the patient’s mandible given the comparable histology. == Physique 1. == Total body fluorodeoxyglucose (FDG) positron emission tomography scan showing multifocal intense FDG uptake in numerous bones, in particular involving the cervical and thoracic spine, the left sacral alar and left femur. == Physique 2. == Superimposed axial CT fluorodeoxyglucose (FDG) positron emission tomography scan of pelvis intense FDG uptake in the left sacral alar. == Physique 3. == Histology slide of left sacral alar. Immunolabelled with AE1AE3 a cytokeratin marker. Serum testing for antiganglioside antibodies was initially unfavorable, but on day 5 of admission it became strongly positive with a titre of 1 1 in 3200 (0200 normal range) by day 13. Investigations for antineuronal antibodies were negative. MRI imaging of the brain and spine was unremarkable. == Treatment == There were no curative or palliative chemotherapy or radiotherapy options for this patient and therefore the priority was symptom control. A course of intravenous immunoglobulins at 2 g/kg was started for 5 days, but this resulted in no neurological improvement. == Outcome and follow-up == She died on day 34 of her admission from respiratory arrest. == Discussion == Here, we present a case of a lady who developed paraneoplastic GBS secondary to a disseminated squamous cell carcinoma. The clinical features of an acute ascending areflexic paralysis with sensory involvement and albuminocytogenic dissociation of CSF fill the Brighton.